How a brain receptor (LRP1) may help tau spread in Alzheimer's

LRP1-tau interactions and Alzheimer Disease

NIH-funded research University of Maryland Baltimore · NIH-11138673

This work looks at whether a brain receptor called LRP1 helps the harmful tau protein spread in people with Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11138673 on NIH RePORTER

What this research studies

From my perspective, researchers are focusing on how tau tangles move through the brain in Alzheimer's by studying a receptor called LRP1. They use brain tissue from people with Alzheimer's and lab-grown cells that either have LRP1 or do not to see if LRP1 helps tau enter cells and seed new aggregates. The team applies biochemical tests and imaging to track tau uptake and the steps that let it escape into the cell cytoplasm. Learning these steps could point to ways to block tau spread and protect nerve cells.

Who could benefit from this research

Good fit: People with Alzheimer's disease (or their families) who can donate brain tissue or participate in associated sample collection would be most relevant to this project.

Not a fit: People without Alzheimer's or those not able to provide relevant tissue samples are unlikely to receive direct benefit from this laboratory-focused work.

Why it matters

Potential benefit: If successful, this work could identify targets for treatments that block tau spreading and slow cognitive decline in Alzheimer's disease.

How similar studies have performed: Prior studies have shown tau can move between cells and that LRP1 binds tau, but how LRP1 enables tau to seed inside cells is still being worked out and is only partly established.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease patient
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.